President & CEO
Stephen F. Flaim, Ph.D., FACC, FAHA
Dr. Flaim holds a doctorate in Human Physiology and Pharmacology from the University of California at Davis. He held faculty positions in Medicine and Physiology at the Pennsylvania State University College of Medicine and senior management roles at McNeil Pharmaceutical, Inc., the Squibb Institute for Medical Research, Alliance Pharmaceutical Corp., Trega Biosciences, Inc. and Galileo Pharmaceuticals, Inc. Dr. Flaim is Founder and President of Flaim Partners Consulting, a Fellow of the American College of Cardiology, the American Heart Association, the American College of Clinical Pharmacology, the Royal Society of Medicine and the American Institute for Medical and Biological Engineering. He is a board member of Pivotal Biosciences, Inc., on the Editorial Board of the Journal of Pharmacology and Experimental Therapeutics, a Technology and Business advisor to the University of California, San Diego, on the Board of Governors of the Tech Coast Angels, on the Executive Board and Vice President of the San Diego Tech Coast Angels, an Entrepreneur-in-Residence with CONNECT, and is also active in numerous regional and national scientific organizations. Dr. Flaim is Cofounder and CEO of CardioCreate, Inc. and Chairman & CEO of OncoFluor, Inc.